The Infectious Diseases Society of America (IDSA) is asking physicians all over the country to speak up and contact Congress about the urgent need for a new drug approval pathway for desperately needed antibiotics. The Special Population Limited Medical Use (SPLMU) mechanism provides an important new approval option for pharmaceutical companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.
Physicians interested in supporting the enactment of this new mechanism can visit http://www.capwiz.com/idsociety/issues/alert/?alertid=61084991 to quickly and easily reach out to their Congress members.
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.